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ABSTRACT: While antimicrobial peptides (AMPs) have
been widely investigated as potential therapeutics, high-
resolution structures obtained under biologically relevant
conditions are lacking. Here, the high-resolution structures
of the homologous 22-residue long AMPs piscidin 1 (p1) and
piscidin 3 (p3) are determined in ﬂuid-phase 3:1 phosphati-
dylcholine/phosphatidylglycerol (PC/PG) and 1:1 phosphati-
dylethanolamine/phosphatidylglycerol (PE/PG) bilayers to
identify molecular features important for membrane destabi-
lization in bacterial cell membrane mimics. Structural reﬁne-
ment of 1H−15N dipolar couplings and 15N chemical shifts measured by oriented sample solid-state NMR and all-atom molecular
dynamics (MD) simulations provide structural and orientational information of high precision and accuracy about these
interfacially bound α-helical peptides. The tilt of the helical axis, τ, is between 83° and 93° with respect to the bilayer normal for
all systems and analysis methods. The average azimuthal rotation, ρ, is 235°, which results in burial of hydrophobic residues in
the bilayer. The reﬁned NMR and MD structures reveal a slight kink at G13 that delineates two helical segments characterized by
a small diﬀerence in their τ angles (<10°) and signiﬁcant diﬀerence in their ρ angles (∼25°). Remarkably, the kink, at the end of a
G(X)4G motif highly conserved among members of the piscidin family, allows p1 and p3 to adopt ρ angles that maximize their
hydrophobic moments. Two structural features diﬀerentiate the more potent p1 from p3: p1 has a larger ρ angle and less N-
terminal fraying. The peptides have comparable depths of insertion in PC/PG, but p3 is 1.2 Å more deeply inserted than p1 in
PE/PG. In contrast to the ideal α-helical structures typically assumed in mechanistic models of AMPs, p1 and p3 adopt disrupted
α-helical backbones that correct for diﬀerences in the amphipathicity of their N- and C-ends, and their centers of mass lie ∼1.2−
3.6 Å below the plane deﬁned by the C2 atoms of the lipid acyl chains.
■ INTRODUCTION
Cationic α-helical antimicrobial peptides (AMPs) are essential
components of the innate immune system and have garnered
much interest in the search for novel antimicrobial agents due
to their direct antimicrobial eﬀects, broad-spectrum activity,
rapid eradication of their targets, potency against drug-resistant
bacteria, and low incidence of induced bacterial resistance.
1−8
Their therapeutic potential is multifaceted since their functions
include bactericidal, fungicidal, virucidal, and tumorocidal
activities as well as immunomodulatory eﬀects that allow
them to coordinate responses from both the innate and
adaptive immune systems.
2,3,6 Their antimicrobial activity,
which is generally due to membrane disruption and
permeabilization, correlates more with their amphipathicity
and ability to induce nonbilayer phases than a speciﬁc motif in
their amino acid sequence.
9,10 The amphipathic α-helix adopted
by many AMPs is an advantageous membrane-binding motif
since it matches the interfacial nature of phospholipid bilayers
and enables both the hydrophilic and hydrophobic sides of the
helix to be involved in membrane binding. Furthermore,
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thermodynamically favorable.
11
The direct relationships between the amino acid composition
of AMPs, their mechanism of action, and the bilayer
composition of their targets are not well understood. On one
hand, amphipathicity has become a major consideration in
engineering therapeutically useful AMPs since it relates to
manipulable properties of the α-helix, such as the amino acid
composition, hydrophobic moment, charge distribution,
orientation of large residues, and relative sizes of the
hydrophobic and hydrophilic sectors.
1,3,12−16 On the other
hand, mounting evidence suggests that the more potent AMPs
do not have perfectly amphipathic secondary structures and the
balance between hydrophobic and electrostatic interactions
involving the peptide, lipids, and water determines the AMP’s
membrane-destabilizing activity. To discern molecular deter-
minants (e.g., deviations from idealized amphipathic structures)
that generate intermolecular forces conducive to membrane
destabilization and to design analogs with predictable
therapeutic eﬀects, rigorous structural and topological analyses
of AMPs with sequence homology but distinct potencies must
be performed under biologically relevant conditions.
The Antimicrobial Peptide Database (APD),
17 which
contains more than 2200 AMPs, indicates that 44% have
known secondary structures (41% have α-helical content; 18%
contain β-sheets) and only 14% have known 3D structures,
90% of which were solved by NMR. Whereas solid-state NMR
(ssNMR) is particularly well suited to investigate the structures
of AMPs under native-like conditions and the structure of an α-
helical AMP, mastoparan-X, was solved by ssNMR in gel-state
bilayers,
18 α-helical AMP high-resolution structures in liquid-
crystalline (“ﬂuid”) phospholipid bilayers are lacking. In this
research, four high-resolution structures of two 22-residue long
AMPs from the piscidin family, piscidin 1 (p1) and piscidin 3
(p3), were determined in ﬂuid 3:1 1,2-dimyristoyl-sn-glycero-3-
phosphatidylcholine (DMPC)/1,2-dimyristoyl-sn-glycero-3-
phosphatidylglycerol (DMPG) and 1:1 1-palmitoyl-2-oleoyl-
sn-glycero-phosphatidylethanolamine (POPE)/1-palmitoyl-2-
oleoyl-sn-glycero-phosphoglycerol (POPG) lipid bilayers to
model the lipid composition of bacteria such as Staphylococcus
aureus (Gram-positive) and Escherichia coli (Gram-negative).
The peptides, which are kinked at a central glycine, are
immersed in the lipids resulting in local bilayer distortion and
global thinning. The substantial structural divergences between
the structures of p1 in bilayers and those previously determined
in SDS (sodium dodecyl sulfate) and DPC (dodecylphospho-
choline) micelles
19,20 highlight the impact of the environment
on AMP structures and the need for structural studies of AMPs
with native-like lipids as presented here.
Piscidins, found widely in teleost ﬁsh and ﬁrst discovered in
mast cells,
21−23 have broad-spectrum activity against a large
number of Gram-positive and -negative bacteria, including
methicillin-resistant S. aureus (MRSA),
24 viruses such as HIV-
1,
25 fungi,
26 yeasts, and cancer cells.
27 The piscidin family
contains homologues that are ideal for probing the relationships
between AMP structure and function. In particular, p1 and p3
have highly conserved N-terminal segments and varied C-
terminal segments. The respective minimum inhibitory
concentrations (MICs) for p1 and p3 are 2−10 and 10−20
μM against E. coli; they are ≤2 and 2−10 μM against Bacillus
cereus.
21,22 Both peptides have an MIC ≤ 2 μM against S.
aureus. P1, which has known membrane permeabilizing
capability,
19,20 is not only more antimicrobial but also more
hemolytic than p3 since the concentration of peptide required
to lyse 50% of red blood cells (EC50) is much lower for p1
(∼50 μg/mL) than p3 (≫100 μg/mL).
28 Signiﬁcantly, a recent
screening of the APD by Wang
6 indicated that p1, which has
anticancer properties,
27 is one of the top six potent AMPs with
anti-HIV-1 activity. With ascaphin-8, p1 is the only AMP that is
active against both a broad spectrum of bacteria (including
MRSA) and HIV-1.
6 These compelling properties translate into
a strong motivation to use piscidin as a template to develop
new therapeutics. Members of the piscidin family contain up to
10 times as many histidines as do other AMPs in the APD
(20% in p1 versus 2% in a group of over 2200 AMPs).
17 These
residues may act as pH-sensitive switches that modulate the
amphipathic character and antimicrobial activity of piscidin.
29
Both p1 and p3, which contain a helix-disrupting G(X)4G motif
between G8 and G13, are intrinsically disordered molecules
that are unstructured in water but form highly α-helical
structures in the presence of lipid bilayers.
30−32 Since the
adsorption of p1 and p3 onto lipid bilayers is a precursor to
dramatic lipid bilayer perturbation and permeabilization under
nonequilibrium conditions and therefore so central to their
mechanism of action, the equilibrium structures and
orientations of these piscidins bound to bilayers could reveal
characteristics that correlate with their distinct biological
activities.
When p1 is bound to anionic SDS micelles, the full length of
the peptide backbone is a straight α-helix. This structure and
that of mutants led to a proposal that a hydrophobic patch at
the N-end facilitates insertion in bilayers.
19 In zwitterionic DPC
micelles, p1 adopts an α-helical conformation from residues 8
through 17, one β-turn at the N-end and two β-turns at the C-
end.
19 Oriented sample solid-state NMR (OS ssNMR) studies
of partially labeled p1 and p3 in phospholipid bilayers that were
either mechanically or magnetically aligned indicated that the
peptides adopt an in-plane orientation.
30,31,33 In the ssNMR
studies, 3:1 DMPC/DMPG bilayers (25% anionic) were used
to mimic negatively charged bacterial membranes such as
Gram-positive S. aureus that have low intrinsic curvature and
are highly susceptible to p1 and p3. Accompanying dynamic
studies in 3:1 PC/PG identiﬁed two possible types of backbone
motions, including a fast diﬀusion in the plane of the bilayer
and a rocking motion about the helical axis.
33 None of the
above-referenced studies provided the high-resolution struc-
tures of p1 and p3. Previously, molecular dynamics (MD)
simulations were used to characterize the dynamics of p1 in
implicit bilayers of diﬀerent geometries
34 and atomistic lipid
bilayers.
35,36 Notably, p1 was found to insert more deeply into
zwitterionic PC than anionic PG bilayers. These MD studies
are an important ﬁrst step in characterizing the interactions of
p1 with lipid bilayers. However, MD simulations on the
protonated forms of p1 were not performed, and p3 was not
considered. Furthermore, the scope of these MD simulations
was limited because no experimentally measured orientations of
the peptide existed to inform the simulations.
OS ssNMR is a powerful technique for the structural studies
of AMPs bound to membranes; however, rigorous structural
characterization relies on incorporating the eﬀect of the peptide
dynamics on the NMR observables.
37−40 There are two primary
routes to obtain the three-dimensional (3D) structures and
orientations of amphipathic peptides from OS ssNMR data.
The ﬁrst is based on the sinusoidal patterns of 1H−15N dipolar
coupling (DC) or 15N chemical shift anisotropy (CSA)
restraints as a function of residue number, commonly denoted
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41,42 For ideal
α-helices, the period and amplitude of the wave are simply
related to the tilt, τ (orientation of the helical axis with respect
to the bilayer normal), and azimuthal rotation angle, ρ (rotation
of the helix around its helical axis) (Figure 1A). Alternatively,
structure determination programs (e.g., Xplor-NIH)
43 can use
ssNMR DC and CSA as restraints in conjunction with a
molecular mechanics force ﬁeld to generate 3D structures by
simulated annealing.
44−46 The balance of CSA, DC, and ϕ/ψ
restraints is important and can greatly aﬀect the reﬁned
structure.
45 These programs typically yield an ensemble of
structures, which are presumed to be representative of the
natural structure and are a starting point of structural analysis.
The structures in the ensemble usually diﬀer from each other
because of numerous local minima on the energy surface. This
is usually not a serious drawback, but when the experimentally
obtained data are an average of substantially diﬀerent
conformations and orientations, a single structure may be an
inaccurate representation. For example, the signiﬁcant diﬀer-
ences in the average tilt of a designed transmembrane helix
(WALP23) determined by NMR and MD simulations were
attributed to bias averaging in the former.
47 MD simulations
can resolve questions on bias averaging since they provide a
time series of the individual orientations that compose the
average. Moreover, if satisfactory agreement between MD and
OS ssNMR is achieved, the atomistic description obtained from
an MD simulation can be relied on to accurately determine
details such as the peptide’s depth of insertion not easily
measured experimentally with OS ssNMR in a membrane
environment.
As subsequently discussed here, the combination of CD and
O Ss s N M Rd a t aw a su s e dt od e t e r m i n et h eg e n e r a l
conformation and orientation of p1 and p3 in 3:1 DMPC/
DMPG and 1:1 POPE/POPG. Peptide structures for the four
systems corresponding to the two peptides in the two lipid
mixtures were independently generated by simulated annealing
reﬁnement of the NMR data and by MD simulations. Excellent
agreement between structures obtained by both methods
strengthened conﬁdence in the depth of insertion and side-
chain orientations determined solely from MD. The rigorous
comparisons of experimental and simulated structures and
orientations of both p1 and p3 in liquid-crystalline lipid bilayers
were analyzed to provide the details necessary to conﬁdently
identify molecular features of the peptides that may aﬀect the
lipid speciﬁcity, bilayer location, membrane-destabilizing
capability, and antimicrobial potency of the peptides.
■ MATERIALS AND METHODS
Materials. The synthesis and puriﬁcation of carboxyamidated p1
(MW 2571) and p3 (MW 2492) have been previously reported.
31
Circular Dichroism. CD experiments for p1 and p3 added to
suspensions of unilamellar phospholipid vesicles at a peptide-to-lipid
ratio of 1:60 were performed following a standard protocol described
previously
28 and brieﬂy outlined in the SI. Percent helical content
given in Table S1 were calculated as explained in the SI.
Preparation of Samples for Solid-State NMR. Oriented
samples were prepared following a procedure previously reported.
28
15N Solid-State NMR. Two-dimensional heterocorrelation (2D
HETCOR)
32 NMR experiments were performed at the National High
Magnetic Field Laboratory on an ultrawide bore superconducting
21.1T magnet with a Bruker Avance 900 MHz NMR console (Larmor
frequencies of 897.11 and 90.92 MHz for 1H and 15N, respectively)
and on a 14.1 T Bruker Avance WB600 NMR spectrometer (Larmor
frequencies of 600.13 and 60.82 MHz for 1H and 15N, respectively)
and at the Rennselaer Polytechnic Institute on a Bruker Avance
WB600 NMR spectrometer (Larmor frequencies of 600.36 and 60.84
MHz for 1H and 15N, respectively). Spectra were obtained using low
electrical ﬁeld PISEMA probes
48 and previously reported parameters
32
that are summarized in the SI. The respective CS of 1H and 15N were
referenced to the proton water peak at 4.7 ppm and the 15N signal of
an 15N-labeled ammonium sulfate aqueous solution (5%, pH 3.1) at 0
ppm.
Ss-NMR samples featured multilamellar vesicles and a peptide-to-
lipid ratio of 1:20, which reﬂects the conditions under which AMPs
similar to piscidin are active
49 and allows for optimal sensitivity of the
NMR experiments. 2D HETCOR experiments were applied to
samples of p1 and p3 oriented with the bilayer normal parallel to
the static magnetic ﬁeld, B0. The experiments consisted of both
HETCOR and dipolar-encoded HETCOR (de-HETCOR) experi-
ments
32 since de-HETCOR OS ssNMR spectra provide both the 1H
and 15N CSA, and their associated 1H−15N DC (i.e., half the dipolar
splitting, DNH). Because DC orientational restraints are very sensitive
to the orientations of peptide planes with respect to B0 and the bilayer
normal, they can be used along with the 15N CSA restraints to
determine the peptide structure and topology. Molecular motions of
piscidin include the diﬀusion of the peptide about the bilayer normal
and the rocking of the peptide about the helical axis.
30,31,33 In the
oriented preparations used here, the bilayer normal is parallel to B0,
and therefore motional averaging is mostly due to rotational diﬀusion
about the bilayer normal. Aside from the helical “fraying” characterized
at the terminal region of the peptides, which may be attributed to
additional local dynamics at the terminal residues, there is no strong
evidence of other possible dynamics, which, if present, have only a
negligible impact on the NMR observables. Indeed, as revealed by the
MD simulations presented in this work, these NMR observables are
reliable restraints to obtain the structure of piscidin with high precision
and accuracy.
Figure 1. Orientation and bilayer position of an interfacially aligned
peptide. (A) Orientation of a peptide that is kinked in the plane
perpendicular to the bilayer surface. The angles (τN,ρN) and (τC,ρC)
are used to characterize the orientations of the helical segments on the
amino (left) and carboxyl (right) sides of the kink. (B) Bilayer location
of the kinked peptide. The depth of insertion of the peptide is deﬁned
as the distance between the center of mass (CM) of the peptide
backbone and the hydrophobic interface deﬁned by the C2 of the bulk
lipids (>10 Å from the nearest peptide). Since the peptide is kinked, a
CM is deﬁned for each helical segment before and after the kink (see
Materials and Methods for details).
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planes of piscidin, a collection of 15N-amide singly and multiply labeled
samples were used. To ensure that correct assignments were made
when multiply labeled samples were analyzed, assignments of p1 in 3:1
PC/PG were done with a large number of singly labeled peptides (H3,
H4, F6, R7, V10, V12, K14, H17, R18, V20). Complete resonance
assignments for the two peptides in the two lipid mixtures are
explained in the SI and summarized in Table S2. Assignments of
signals from each peptide were done using an iterative process where
the experimental data were ﬁtted with dipolar waves as described
under Dipolar and Chemical Shift Wave Analysis. Various
permutations of assignments in multiply labeled samples were tested.
Based on the chemical shifts range of 37−73 ppm and polarity index
slant angle (PISA) wheel simulations previously done on a 10-site
labeled p1 sample in 3:1 PC/PG,
32 the tilt angle was determined to be
close to 90°. Therefore, waves were generated with this starting value
and changed until a combination of τ and ρ yielded a good ﬁt between
experimental data and simulated waves. Due to ambiguities that arise
from the symmetry of nuclear spin interactions, two peptide
orientations were consistent with the wave analysis: 180° − τ/ρ and
τ/180° + ρ, with 0° < τ < 180° and 180° < ρ < 360°. These
orientations are magnetically equivalent but chemically nonequivalent
when a peptide is considered in a given leaﬂet of the bilayer.
Considering the upper leaﬂet where by convention the bilayer normal
is pointing up along the z-axis and B0, the τ/180° + ρ combination
corresponds to a peptide that directs its hydrophobic side chains
toward the hydrophobic bilayer, while the other combination of 180°
− τ/ρ points the hydrophilic side chains toward the core of the bilayer,
which is energetically unfavorable. As a result, it is possible to identify a
single orientation for each piscidin. Corresponding helical wheel
diagrams are shown in Figure 2.
Structure Determination. Reﬁned NMR (NMRr) structures
were obtained using a simulated annealing protocol within Xplor-
NIH
43 with torsion angle MD in the presence of the experimental
restraints.
45 Simulated annealing was performed by reducing the
temperature from the initial value of 2000 to 50 K in steps of 12.5 K.
Ideal ϕ/ψ angle restraints (−65°/−40°) with ±20° variation were
used for all residues with kta ramped from 300 to 100 kcal·mol−1·rad−2.
krdc was gradually increased from 2 to 5 kcal·mol−1·s2, and kcsa was set
constant at 0.1 kcal·mol−1·s2 in order to be consistent with the
experimental error. These force constants, which correspond to a
CSAscale/DCscale < 0.1, were chosen to obtain the optimal balance
between the eﬀects of the DC and CSA restraints in the structure
calculations.
45,46 The NMR restraints were taken from bilayer samples.
To match the experimental conditions, the orientation tensor axial
component Da was set to an initial value of 10.4 kHz and reﬁned to
∼9.8 kHz. Rhombicity (Rh) was ﬁxed at zero for all calculations. The
calculation also included the Xplor-NIH potential for knowledge-based
torsion angles with ramped force constants of 0.002 to 1 kcal·mol−1·
rad−2. kvdW and svdW were geometrically increased from 0.004 to 4 kcal·
mol−1·Å−4 and 0.9 to 0.8, respectively. Routine terms ANGL, BOND,
and IMPR were also added to the calculation. A total of 100 structures
were generated, and the 10 lowest-energy structures were accepted for
analysis and representation. The same setup was employed for each
structure calculation. The atomic coordinates for the 10 lowest-energy
structures of the four systems have been deposited in the Protein Data
Bank under the ﬁle names 2MCU, 2MCV, 2MCW, and 2MCX.
Charge State of the Histidine Side Chains. Investigating the
charged state of the histidine side chains in membrane-bound piscidin
was done by performing OS ssNMR on aligned samples of p1 in 3:1
PC/PG at the higher pH of 8.8 to be above the pKa of the histidine
side chains and provide conditions to study the peptide’s structure
when the histidine side chains are neutral.
Figure 2. Helical wheel diagrams rotated to match the ρN and ρC of the reﬁned NMR structures (NMRr; left set) or the MD structures (right set). In
each set, p1 (left) and p3 (right) are shown in 3:1 PC/PG (top) and 1:1 PE/PG (bottom). Residues in green indicate more polar groups, while
those in light orange are hydrophobic; histidines and glycine are in blue and gray, respectively. The orientation of the hydrophobic moment (μH) is
identiﬁed with an orange arrow. The coordinate system that deﬁnes ρ is given in the Orientation from NMRr and MD Structures section.
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Simulations were performed using CHARMM 36b2
50 with CHARMM
22 protein parameters
51 and CHARMM 36 lipid parameters
52 with
modiﬁed Lennard-Jones pairwise distances for sodium ions interacting
with select lipid oxygens.
53 Each system was composed of 80 lipids,
two peptides (1 per leaﬂet), a water layer ∼16 Å thick above and
below the bilayer, 16 sodium ions, and chloride ions to neutralize the
system. The 1:40 peptide:lipid ratio (half that of the NMR
experiments) was chosen to study the peptides at low concentration,
before they interact with each other along the bilayer plane.
Initial structures of p1 and p3 were generated with ϕ/ψ angles of
−61° and −45°, respectively, and extended side chains. One peptide
was aligned with the center of mass (CM) of its heavy backbone atoms
14 Å above the center of the bilayer, while the second peptide was 14
Å below the bilayer. This initial position yields a bilayer location of the
peptide that is no deeper than the C2 atoms of the lipids. To minimize
interaction across the bilayer, the peptides were rotated to be
perpendicular to each other with respect to the bilayer normal. Each
peptide was rotated around its helical axis to ensure that hydrophobic
residues were facing the bilayer core. Systems were assembled using
the CHARMM-GUI interface.
54 Separate simulations of p1 and p3
were performed with diﬀerent charge states of the histidine side chains
as shown in Table 1. Peptides were simulated with neutral histidine
side chains unless otherwise indicated in the text.
In all simulations, speciﬁc Lennard-Jones cutoﬀs and particle-mesh
Ewald
55 electrostatics were required for the preceding force ﬁelds.
52
The Lennard-Jones potential terminated at 12 Å, with a smoothing
function operating between 8 and 12 Å. The Nosé-Hoover algorithm
with thermal piston value of 10 000 kcal/mol·ps2 was used to control
temperature.
56,57 A Langevin piston with a piston mass of 1000 amu
maintained a constant normal pressure of 1 atm and zero surface
tension.
58 The temperature was held constant at 313 K. Trajectories
were generated with a leapfrog Verlet algorithm with a time step of 1
fs. All bonds to hydrogen atoms were constrained using the SHAKE
algorithm.
59 The initial 10 ns of each trajectory were removed to allow
for equilibration, and the ﬁnal 90 ns were used for analysis. Peptide
orientations and depths of insertion were calculated as averages over
10 ns blocks of simulation time.
Dipolar and Chemical Shift Wave Analysis. The 15N−1HD C
and 15N CSA restraints were ﬁtted to waves as described by Perrin et
al.
60 and summarized brieﬂy in the SI.
Orientation from NMRr and MD Structures. In the oriented
samples analyzed here, the z-axis is parallel to the bilayer normal and
B0, which by convention points up along the z-axis. As shown in Figure
1A, the molecular frame is deﬁned using hx, hy, and hz; hx is the radial
vector going through the center of the helix and the Cα of the ﬁrst
residue in the peptide sequence; hz is the helical axis; and hy is
orthogonal to hx and hz. The orientation of each peptide is
characterized by τ and ρ (Figure 1A). These orientations correspond
to the Euler angles (α, β, γ), where τ(β) is the tilt of the peptide and
ρ(γ) is the rotation of the Cα from residue 1 around the helical axis.
The tilt, which is equal to zero when hz is parallel to the z-axis (Figure
1A), is measured as a clockwise rotation of the helix away from B0.
Following the convention of Cross and co-workers,
61 ρ, which is zero
when hx is aligned along the positive direction of the z-axis, is
measured as a counterclockwise rotation about hz (Figure 1A). The
Table 1. MD Simulations Presented in This Study
a
peptide lipid charged histidines
p1 3:1 DMPC/DMPG none
p3 3:1 DMPC/DMPG none
p1 1:1 POPE/POPG none
p3 1:1 POPE/POPG none
p1 3:1 DMPC/DMPG 3, 4, 11
p1 3:1 DMPC/DMPG 3, 4, 11, 17
p3 3:1 DMPC/DMPG 3, 4, 11
aAll simulations were run with a protein/lipid ratio of 2:80.
Figure 3. 2D de-HETCOR NMR spectra of p1 (left) and p3 (right) in oriented, hydrated 3:1 DMPC/DMPG (top) and 1:1 POPE/POPG
(bottom). Spectral superimpositions of singly to triply labeled samples are shown. The peptide-to-lipid ratio was 1:20 (molar). The spectra were
collected at 305 (1:1 POPE/POPG) and 313 K (3:1 DMPC/DMPG), above the phase transition temperature of the lipids. Each pair of 15N/1H
splittings (DNH) is shown using a single color. In addition to 15N backbone amide labels, the arginine side chains also contained 15N sites, some of
which were detected in the de-HETCOR spectra. Only the backbone signals are annotated. The de-HETCOR data for G22 p1, which are outside the
range of the spectra shown here, and the PISEMA data for F6I9A12 p3 in DMPC/DMPG are included in Figure S2.
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relative to a piscidin structure with known orientation (ϕ/ψ angles of
−61°/-45° and all Euler angles set to zero). The depth of insertion of a
peptide was calculated as the distance between the CM for heavy
backbone atoms and the C2 atom of chain 2 of each bulk lipid
molecule in the same leaﬂet. Bulk lipids were deﬁned as any lipid at
least 10 Å away from the nearest peptide. Separate CMs for residues
3−10 and 14−20 were used to avoid artifacts due to fraying of
terminal residues and kinking at G13 and obtain reliable depths of
insertion for the N and C segments (Figure 1B).
Statistical Analysis. A subsection that describes the statistical
analysis used for the reﬁned NMR structures and MD simulations is
provided in the SI.
■ RESULTS AND ANALYSIS
Circular Dichroism. The CD spectra of p1 and p3 collected
in the presence of 3:1 PC/PG and 1:1 PE/PG in phosphate
buﬀer at pH 7.4 (Figure S1) and 6.0 display the two minima of
222 and 208 nm that are characteristic of α-helical structures,
therefore both peptides become highly α-helical in the presence
of these phospholipids (Table S1).
High-Resolution Solid-State NMR of p1 and p3 in
Lipid Bilayers. Both p1 and p3 contain 21 peptide planes. To
investigate the structure and orientation of each peptide in a
given oriented lipid mixture, the 21 peptide planes were 15N-
labeled and subjected to OS ssNMR spectroscopy. In the de-
HETCOR spectra (Figure 3), 17−21 DC and 17−21 15NC S
values were detected and summarized in Table S2. The sharp
signals indicate structural homogeneity and stability of the
corresponding labeled amide sites. Importantly, these spectra
show no indication of signal from isotropically mobile residues
or underlying powder pattern signal that would indicate a
subset of static or unoriented peptide molecules. The 15N
resonances are clustered between 37 and 73 ppm, as expected
for α-helical amphipathic structures with an in-plane bilayer
orientation.
37−39 The single DC restraint associated with each
labeled amide site reﬂects the orientation of the peptide with
respect to B0 a n dt h e r e f o r ei sc r u c i a lt os t r u c t u r a l
determination. DC and/or CSA orientation restraints that are
missing or close to isotropic values are consistent with
structural heterogeneity and helical fraying on the NMR time
scale (μs for the 15N CSA) and a more dynamic nature of
terminal residues where some of the main chain carbonyl and
amide groups are not hydrogen-bonded. Accordingly, no DC
could be obtained for position 1 of p1 and p3 in all lipid
systems, and orientational restraints for p3 were detected at
neither position 2 in both lipid systems nor position 3 in PE/
PG. These results indicate that p3 has more structural
heterogeneity than p1 at the amino end, and 1:1 PE/PG
induces more structural ﬂuctuations in p3 than 3:1 PC/PG
does. Further scrutiny reveals that the NMR data, which are
consistent with the highly yet partial helical conformation
determined by CD spectroscopy, help assign the small
deviation in helical content to the terminal residues where
dynamic fraying is detected on the NMR time scale.
Use of Dipolar Waves to Characterize the Local
Backbone Structure of p1 and p3. To characterize the local
backbone structure of p1 and p3, the experimental 15N−1HD C
restraints obtained from the aligned samples were plotted as a
function of residue number and shown in Figure 4. Three
structural features are obtained from these plots.
41,60 First, α-
helical segments are revealed between residues 3−10 and 14−
20 since the corresponding experimental data points can be
ﬁtted to a sinusoidal wave (gray line) with a periodicity of 3.6.
41
Second, the fact that some experimental points at the N- and C-
ends cannot be ﬁtted with such a wave indicates that the
corresponding residues are experiencing helical fraying. Third,
the necessity to ﬁt residues 3−10 and 14−20 separately
demonstrates the presence of a kink at G13. These three
ﬁndings are conﬁrmed by the 15N CSA restraints plotted in
Figure S3. While dipolar and chemical shift waves have been
established as a useful tool for structural analysis,
41,42 they have
largely been superseded by structure determination programs
like Xplor-NIH that combine both the DC and CSA restraints
along with aspects of covalent bond geometry.
44−46 The next
section covers the 3D structural determination of p1 and p3 by
Xplor-NIH.
3D Structures of p1 and p3 Bound to Lipid Bilayers.
15N−1H DC and 15N CSA values obtained from the de-
HETCOR spectra were used as restraints in Xplor-NIH to
calculate the atomic-level structures of p1 and p3 in 3:1 PC/PG
and 1:1 PE/PG. The excellent agreement between the
experimental dipolar splittings and CSA values and those
calculated from the four reﬁned structures is demonstrated in
Figure 5 by the low rmsd of 0.36 to 0.51 kHz and 3.0 to 3.9
ppm, respectively. For each system, Figure 6 shows an overlay
of the top 10 structures (ensemble) and the lowest-energy
structure that were obtained upon reﬁnement of the NMR
restraints. Table S5 summarizes the NMR structure statistics,
and Figure S4 shows the surface of each peptide based on
amino acid type. Considering the backbone heavy atoms of
residues 3−20 that exhibit α-helicity (Figure 4), the rmsd
between the top 10 peptide structures of each ensemble and
their mean structure is in the range of 0.35−0.39 Å as shown in
Table S5 (the table also gives rmsd values between the top 10
Figure 4. DC restraints experimentally observed (black), calculated
from the reﬁned NMR structures (green) and calculated from the MD
simulations (red): p1 in 3:1 DMPC/DMPG (top) and 1:1 POPE/
POPG (bottom-middle) and p3 in 3:1 DMPC/DMPG (top-middle)
and 1:1 POPE/POPG (bottom). Absolute values of the dipolar
couplings are plotted. Dynamics on the NMR time scale led to a lack
of de-HETCOR signals for some of the terminal residues (Table S2).
Dipolar waves ﬁtted to the experimentally observed DC between
residues 3−10 and 14−20 are shown in gray for an ideal α-helix with
dihedral angles (ϕ = −61°, ψ = −45°). These α-helical regions are
identiﬁed on the basis of having low ﬁtting errors (average error per
residue that is less than or similar to the experimental error of ±0.5
kHz).
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these structures high resolution,
62 is better than values typically
obtained for membrane protein structures solved by ssNMR
63
and substantiates the results from wave analyses.
MD Simulations. In all simulated systems, piscidin
remained predominantly α-helical and interfacially oriented
throughout the 90 ns trajectory. The MD structures are
consistent with the experimental NMR restraints and structural
features of the reﬁned NMR structures. Indeed, the DC and
CSA calculated from the MD structures (Figure 4) have an
rmsd of 1.05−1.46 kHz and 7.31−10.94 ppm from the original
NMR values for residues 3−20 (4−22 for p3 in PE/PG). This
comparison cross-validates the NMR and MD data and
demonstrates the accuracy of the structures. Furthermore,
fraying of terminal residues is indicated by smaller DC values
simulated for residues 2, 3, and 22 (Figure 4). On this basis, N-
terminal fraying is greater in p3 than p1 in agreement with the
NMR data. Additionally, kinking at G13 is manifested by a
change in the pattern of the MD data points that coincides well
with that observed by NMR (Figure 4).
Comparison of p1 and p3 in Terms of Orientations
Determined from the Reﬁned NMR and MD Structures.
Characterizing accurate peptide orientations is critical to further
interpretation of the results in terms of structure−function
relationships. Here, the agreement demonstrated between the
high-precision reﬁned NMR and average MD structures and
orientations is seen as accuracy in the descriptions of the
piscidin peptides in terms of conformation and topology. The
tilt angles τ and azimuthal rotation angles ρ were calculated
separately for residues 3−10 and 14−20 due to the kink at G13,
and their respective diﬀerences are Δτ (τN − τC) and Δρ (ρN −
ρC), where the subscripts N and C denote the N- and C-ends,
respectively. The orientations, summarized in Table 2, have
average τ near 88° (parallel to the surface) and average ρ
around 235°. With the exception of p1 in PE/PG, τ values from
MD are within 2 standard errors (SE) of those from NMRr,
indicating statistical equivalence. Figure 7 and Table 2 show
that the root-mean-square ﬂuctuations (rmsf) from simulations
are 7 to 9° based on the MD data. This reﬂects the highly
dynamic nature of the interfacially bound piscidin peptides. All
of the τ from NMR are within ±1.3 rmsf of the MD values,
further indicating that the deviations are of minor consequence.
A more rigorous statistical comparison is diﬃcult because the
standard deviations in τ from the NMR structures (1−3°) are
incomplete measures of uncertainty; i.e., SE obtained from a
larger set of independent structure determinations are likely
higher than the present standard deviations. The ρ from MD
are mostly higher than those from NMR, and the diﬀerences
are usually more than 2 SE. Nevertheless, the trends are
comparable, and the values from NMRr are within 2.5 rmsf in
all cases; i.e., the structures from MD are frequently sampling
the values of ρ from the NMR structures. Overall, p1 has larger
average ρ than p3 (average ρC derived from the NMR
structures are similar for both peptides, but the corresponding
MD values are more reliable since they are not susceptible to
bias averaging). The ﬁnding that ρ is the orientational quantity
most pertinent to diﬀerentiate p1 from p3 is illustrated in
Figure 2, where helical wheels for each peptide are rotated to
their corresponding values of ρ (Table 2). Rotations are
performed using a convention where B0 and the bilayer normal
are pointing up along the z-axis and the angle ρ, which is equal
to zero when the ﬁrst residue in the sequence is at the 12
o’clock position, is measured as a counterclockwise rotation of
the helical wheel about the helical axis. From these diagrams, it
is evident that ρ ∼ 235° evenly distributes the hydrophilic
residues at the water-bilayer interface, while the hydrophobic
residues face the hydrocarbon core of the bilayer. This hallmark
orientation of piscidin is illustrated in Figure 8 that shows a
MD snapshot of each system with orientation and depth of
insertion characteristic of the average structure.
Characterization of the Kinked Structures and their
Hydrophobic Moment. The availability of high-resolution
and accurate structures of p1 and p3 enables detailed
conformational comparisons. As illustrated in Table 2 and
Figures 2 and 4, both the NMR and MD data show that p1 and
p3 have a slight bend or kink characterized by a small change in
τ (Δτ <1 0 °) and a larger change in ρ (Δρ ≈ 20° for MD and
≈30° for the reﬁned NMR structures). Staggered helical wheels
can be used to illustrate Δρ, as shown in Figure 2. Residues 1−
13 and 14−22 are plotted as two diﬀerent concentric circles,
with residues 14−22 having a smaller radius. When the
uncertainties in ρ of 2−4° for the NMR structures and rmsf in
ρ of 10−13° for the MD structures are considered, the helical
wheels derived from the reﬁned NMR and MD structures and
shown in Figure 2 have consistent helical rotations within the
range of ﬂuctuations obtained by MD. This corroborative
Figure 5. Correlation plots between calculated and experimental
dipolar splittings, DNH (left) and CSA (right). Values calculated from
the reﬁned NMR structures are plotted as a function of the original
NMR values. The rmsd for residues 3−20 are shown.
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the geometric conﬁgurations.
To determine the driving force behind the diﬀerent helical
rotations on each side of G13, the peptide’s amphipathicity and
more speciﬁcally the hydrophobic moment (μH) of each
peptide as a function of Δρ were considered. This is illustrated
in Figure 9 using the White and Wimley interfacial hydro-
phobicity scale.
64 On that scale, p1 has a slightly larger
hydrophobic moment than p3. Figure 9 shows that the helical
segments on each side of the kink adopt distinct mean
orientations that maximize the overall hydrophobic moment of
the peptide and therefore its hydrophobic contacts with the
bilayer hydrocarbon core. Overall, relative values of ρ are
diﬀerent for p1 and p3, but the peptides ﬂex similarly as
measured by Δρ to optimize their hydrophobic moment. Thus,
the diﬀerent amino acid compositions of p1 and p3 translate
into diﬀerent absolute helical rotations, but the amount of
ﬂexing at the conserved G13 is the same for both peptides.
Figure 6. Ten lowest-energy backbone structures (left) and ribbon structures for the lowest-energy conformations (right) of p1 and p3 in 3:1
DMPC/DMPG and 1:1 POPE/POPG. These Xplor-NIH reﬁned structures were calculated using ssNMR 15N chemical shifts and 15N/1H dipolar
couplings. Peptides are aligned with the N-termini on the left. Considering residues 3−20 that show α-helicity, the rmsd values between the top 10
structures of each ensemble and their mean structures are 0.39 and 0.37 Å for p1 in PC/PG and PE/PG, respectively, and 0.39 and 0.35 Å for p3 in
PC/PG and PE/PG, respectively (Table S5). Cross-correlation plots between experimental and calculated 1H−15ND NH and 15N CSA are shown in
Figure 5. Three properties obtained from the MD simulations are included to show the average position of the C2 plane of the bulk lipids
(horizontal blue line) relative to the ﬁxed peptide: the z-position of the CM for backbone atoms of residues 3−10 and residues 14−20 (red dot); the
average depth of insertion of the peptide (the distance between the blue line and red dot); and the ﬂuctuations of the C2 plane with respect to the
CM of the peptide (light blue horizontal band with thickness ±2rmsf = ±1.8 Å). Hence, the C2 plane ﬂuctuates within the blue band with respect to
the peptide.
Table 2. Tilt Angles τ (°) and Azimuthal Rotation Angles ρ (°) Obtained from the Reﬁned NMR Structures (NMRr) and MD
Simulations and Depth of Insertion z (Å) from MD for the N- (residues 3−10) and C- (residues 14−20) Helical Segments of
Each Peptide
a
residues 3 to 10 residues 14 to 20 kink
NMRr MD NMRr MD NMRr MD
avg avg rmsf avg avg rmsf avg avg rmsf
τN τC Δτ =( τN − τC)
p1 PC/PG 90 (2) 91 (1) 7 86 (1) 87 (2) 9 4 (2) 5 (1) 8
p3 PC/PG 91 (1) 93 (2) 7 84 (1) 85 (2) 8 7 (2) 7 (1) 8
p1 PE/PG 83 (3) 92 (2) 8 86 (1) 90 (2) 9 −3 (3) 2 (1) 7
p3 PE/PG 92 (1) 93 (2) 7 83 (2) 86 (2) 8 9 (3) 7 (1) 7
ρN ρC Δρ =( ρN − ρC)
p1 PC/PG 246 (3) 265 (3) 11 213 (1) 245 (3) 13 33 (4) 21 (1) 8
p3 PC/PG 236 (2) 245 (3) 11 215 (2) 225 (3) 11 20 (2) 20 (1) 8
p1 PE/PG 253 (2) 256 (3) 13 218 (2) 236 (3) 12 35 (4) 20 (1) 8
p3 PE/PG 250 (2) 241 (3) 11 220 (2) 223 (2) 10 30 (3) 18 (1) 8
zN zC Δz =( zN − zC)
p1 PC/PG − 3.4 (0.1) 0.8 − 3.3 (0.1) 0.8 1.7 (0.1) 0.1 (0.3) 1.3
p3 PC/PG − 3.7 (0.1) 0.9 − 3.4 (0.1) 0.9 2.2 (0.1) 0.3 (0.3) 1.4
p1 PE/PG − 1.0 (0.1) 0.8 − 1.4 (0.1) 0.8 0.9 (0.1) −0.4 (0.4) 1.6
p3 PE/PG − 2.4 (0.1) 0.9 − 2.3 (0.1) 0.9 1.6 (0.1) 0.1 (0.4) 1.5
aTo characterize the kink, diﬀerences in tilt (Δτ), azimuthal rotation (Δρ), and depth (Δz) between the N- and C-segments are also provided. For
each system, the uncertainties indicated in parentheses by the NMRr and MD angles correspond to standard deviations among the top 10 NMR
structures and SE of the MD data calculated from 10 ns blocks, respectively. The rmsf from MD are also included.
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simulations were used to position the peptides in the bilayers
and identify peptide−lipid interactions. These interactions are
likely to play an important role in the peptide’s function since
they provide a framework from which the peptide can remodel
and disrupt the bilayer. In each simulation, the CM of the
peptide lies within the hydrophobic section of the membrane
and just below the C2 atom of the second acyl chains of the
lipids (Tables 2 and S3). Based on these data, the CM of both
p1 and p3 ﬂuctuates between 2 and 5 Å below the C2 atoms in
3:1 PC/PG (Figure 7), and the depths of insertion are
indistinguishable. The situation is diﬀerent in PE/PG since the
peptides are signiﬁcantly less inserted with p1 and p3 being 2
and 1 Å closer to the hydrophilic medium, respectively. The
change in the peptide’s depth of insertion between 3:1 PC/PG
and 1:1 PE/PG correlates well with the greater propensity for
interactions of the peptides with the headgroup region of 1:1
PE/PG probably because PE is smaller and more accommodat-
ing than PC and/or the ionic content is greater in 1:1 PE/PG
than 3:1 PC/PG. For reference, the depths of insertion from
MD are added to the diagrams of the reﬁned NMR structures
in Figure 6. Table 2 lists the diﬀerence in depth of insertion
between the N- and C-helical segments of each peptide (Δz)
for both the NMRr and MD structures. This quantity ranges
from 0.9 to 2.2 Å for the NMR structures, indicating a slight
burial of the N-terminal segment with respect to the C-
terminus. In contrast, Δz is smaller for the MD structures (Δz
± SE brackets zero in all cases) indicating that on average the
N- and C-terminal segments experience similar depths of
insertion. However, the rmsf for Δz is ∼1.5 Å from MD (Table
2), so the instantaneous Δz values from the simulations sample
those from the NMR structures, as do the τ and ρ values.
As illustrated in Figure 8, phenylanalanines at the N-end
reach well below the C2 atoms. For instance, F1 and F2 of p1
are buried 5.3 and 6 Å below the C2 atoms in PC/PG,
respectively. While histidine side chains form a ridge at the
interface between the polar and nonpolar regions of the
membrane, the tips of the arginine and lysine residues reside in
the headgroup region of the lipids where they snorkel to
hydrogen bond and form salt bridges with the glycerol and
phosphate groups of the lipids. On the N-side of the kink at
G13, multiple phenylalanines facilitate deep insertion into the
membrane whereas on the C-side, the electrostatic interactions
Figure 7. Distribution of tilt angles (top), azimuthal rotation angles
(middle), and depths of insertion (bottom) sampled by p1 (left) or p3
(right) in PC/PG (red) or PE/PG (green) during the entire MD
simulation (90 ns). Curves for N- and C-terminal residues are shown
as solid and dashed lines, respectively.
Figure 8. Snapshots of p1 and p3 in lipid bilayers from the MD
simulations at a time step in which τN, τC, ρN, and ρC corresponded to
the average orientations listed in Table 2. Hydrophobic residues are
colored in orange, polar and charged residues in green, and the C2
atoms of the acyl chain in the lipids are indicated by cyan spheres. Two
peptides were included in the simulations such that there was one
peptide per leaﬂet, and the two peptides were oriented perpendicular
to each other at the beginning of each simulation.
Figure 9. Hydrophobic moment (μH) versus Δρ for p1 (blue) and p3
(red) determined by rotating a helical wheel for residues 13−22
relative to a helical wheel for residues 1−12. Energies are from the
White and Wimley interfacial hydrophobicity scale.
64 Vertical gray
band represent the range of Δρ calculated from the reﬁned NMR and
MD structures. The black line is positioned at Δρ = 0 (peptide with no
kink).
Journal of the American Chemical Society Article
dx.doi.org/10.1021/ja411119m | J. Am. Chem. Soc. 2014, 136, 3491−3504 3499between the lipid headgroups and the arginine and lysine
residues at positions 14 and 18 drive the peptide to point
toward the bilayer surface.
40,65,66
Charge State of the Histidine Side Chains in 3:1 PC/
PG Bicelles. Peptide charge is an important consideration in
mechanistic studies of AMPs since it plays a major role in
deﬁning AMP−lipid interactions that the peptide relies on for
membrane activity. Membrane-active peptides rely on arginine
and lysine side chains for cationicity since their very high pKa
favors the protonated and positively charged state in a
membrane environment.
66 However, histidine side chains
have a much lower pKa (with an average of ∼6), therefore
their charge state is most reliably determined in situ.T o
investigate their charge state in piscidin bound to lipid bilayers,
OS ssNMR experiments were performed on p1 in PC/PG and
supplemented with MD simulations done with diﬀerent charge
states of the histidine side chains. The ssNMR experiments
oﬀer the following two advantages: (1) only the bound state is
detected since the unbound form is too dynamic to cross
polarize; and (2) if a bound peptide exists in diﬀerent charged
states, their structures, orientations, and membrane locations
will most likely diﬀer (see depth from MD in Table S3) and
lead to broad or even split NMR signals. At pH 6.0, single and
sharp signals are obtained for each 15N resonance throughout
the helical backbone of piscidin in both PC/PG and PE/PG
(Figure 3, Table S2), therefore a single charge state of the
peptide with each histidine side chain being either neutral or
protonated must exist. As seen in Table S4, NMR structural
parameters collected at pH 6.0 and 8.8 within the helical core
(between positions 5 and 20) of p1 in 3:1 PC/PG are pH
stable. This indicates that the same protonation state of the
peptide is detected at both pH values and the neutral form of
the four histidine side chains present at the higher pH of 8.8
must also be the one observed at pH 6.0. At position 2, the
NMR restraints indicate that the fraying detected at pH 6.0
remains at pH 8.8. However, these eﬀects are small since no
major change in helicity was detected by CD when the pH was
dropped from pH 7.4 to 6.0 (Table S1).
These ssNMR results are corroborated by the MD
simulations performed on p1 and p3 with neutral histidine
side chains since the structures and orientations derived from
NMR and MD are in good agreement, as presented above.
Furthermore, the sharp NMR signals indicate that the peptides
are strongly bound to the bilayer, which is consistent with the
MD results that each peptide’s CM inserts below the C2 atoms
(Table S3). In contrast, the MD simulations done in PC/PG
for p1 and p3 with charged histidine side chains show
signiﬁcant decreases in the peptide burial compared to those
with neutral histidines. The protonation of H17 in addition to
H3, H4, and H11 in p1 has more dramatic eﬀects in two ways:
it causes a 2.9 Å decrease in burial of the C-terminal segment of
peptide (Table S3) and a 5° decrease in both τN and τC. This
altered equilibrium bilayer orientation and positioning of p1
with four charged histidines is not consistent with the
orientations derived from OS ssNMR data (Table 2) and
therefore supports the neutral state of the histidine side chains
of p1.
■ DISCUSSION
Detailed Structural and Topological Determination of
Amphipathic Helices Bound to Lipid Bilayers. AMPs are
powerful multifunctional molecules that have inspired the
design of new antimicrobial agents and methods of treatments.
To improve the rational design of AMPs and to reﬁne the
overly simpliﬁed structures used in mechanistic models of
AMPs, atomic-level information has been collected on p1 and
p3. As noted in the Introduction, p1 is fully helical in SDS
micelles, while only 45% of the peptide is helical in DPC
micelles.
19,20 The use of native-like bilayers reveals an
intermediate structural behavior since the peptides are highly
helical and generally straight but are frayed at their extremities
and have a kink described by a 25° change in ρ between their
N- and C-terminal residues. Formation of secondary structure,
in this case helical, was expected since it is a main energetic
driving force for membrane binding of amphipathic peptides
and corresponds to a nonclassical hydrophobic eﬀect for which
binding is accompanied by negative enthalpy and entropy
changes.
67 Since the ﬂexing at G13 enhances the hydrophobic
moment of the peptides, it also improves the amphipathicity of
the α-helix and therefore provides an energetic advantage. The
piscidin peptides are less helical and inserted in 1:1 POPE/
POPG than 3:1 DMPC/DMPG (Tables S1 and S3). Similar
eﬀects have been observed for other AMPs studied in the
presence of bilayers containing PE and/or higher anionic
content.
68−76
The process of cross-validating the NMR and MD results as
performed here establishes a rigorous approach for the detailed
determination of in-plane helical structures and allows for the
examination of speciﬁc details such as helical kinks, rotations,
and ﬂuctuations, all of which may be important for function.
Four primary points are learned from approaching structural
work in this manner. First, CD and MD are necessary to
reinforce the need for greater priority on the DC over the CSA
in reﬁning the piscidin structures. The lower reliability of the
CSA for this structural work may come from using a common
15N chemical shift tensor for all nonglycine residues;
45,77 this
approximation does not accommodate the possibility of small
variations in rhombicity of the 15N CS tensors, which could be
an important consideration for peptides that take on
orientations nearly perpendicular to B0. In contrast, trans-
membrane helices may have smaller site to site variations in the
axial components of their chemical shift tensors.
78 Second, in
the case where the peptide ﬂuctuates with τ around 90°±10°
and ρ around 240°±20° as determined by MD, the
orientation of the time-average structure determined by
reﬁnement of the NMR data is very close to the average
orientation directly obtained by MD, i.e., without bias
averaging. This is consistent with previous studies that have
shown insigniﬁcant experimental bias in the average τ when
ﬂuctuations in τ are <20°.
47 Third, the rmsf for the azimuthal
angles ρN and ρC is slightly larger (10−13°) than that of the tilt
(7−9°), and together they illuminate the diﬃculty in describing
these peptides by a single structural representation. The
dynamic nature of interfacially bound peptides is an inherent
behavior and worth determining since it may have functional
meaning.
28,33 Fourth, with consistency between the structures
characterized by CD, dipolar waves, reﬁnement of the NMR
data, and MD, detailed comparisons of p1 and p3 in 3:1 PC/
PG and 1:1 PE/PG bilayers can be conﬁdently derived.
Agreement also strengthens conﬁdence in simulated atomistic
characteristics of p1 and p3 such as their ﬂexibility at G13 and
depths of insertion. Moreover, since structures in MD
trajectories cover a large conformational space while those
reﬁned from NMR represent an average, the MD simulations
are useful in characterizing ﬂuctuations on the orientation and
depths of insertion of the peptide. Next, the orientations and
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content and bilayer composition.
Inﬂuence of Amino Acid Content on Peptide
Orientation. In both PC/PG and PE/PG, the drive for
optimized hydrophobic contacts between the bilayer hydro-
carbon core and the peptides that have diﬀerent amphipathicity
at their N- and C-ends translates into tilted peptide orientations
(τ ≠ 90°), a kink at the end of a G(X)4G motif, and sequence-
dependent helical rotations on each side of this kink. Rotating
and ﬂexing are expected for these amphipathic peptides that are
energetically driven to maximize their hydrophobic contacts
with the membrane. The existence of a slight kink at G13 rather
than an abrupt turn or bend is consistent with the ﬁnding by
Lee et al.
20 that the G13P mutation in p1 produces a peptide
with lower helical content and impaired antimicrobial eﬀects, as
expected if the length of the C-terminal helix was critical to the
peptide’s antimicrobial function. In general, p1 has a greater ρ
than p3 indicating that piscidin’s orientation is dependent on
the amino acid content. In this regard, aromatic residues known
to be important for membrane partitioning and binding are
very inﬂuential.
64,73 Indeed, the average MD values of ρN
(260°) and ρC (240°) for p1 (Table 2) allow H17 on the C-
side of the kink to optimize its location in the hydrophilic
region of the lipids, while the aromatic side chains of F1, F2 and
F6 on the N-side of the kink are able to bury themselves in the
hydrophobic core of the bilayer sitting 5−6 Å below the C2
atoms. A similar enhancement of interactions is displayed by p3
as a result of being kinked, but its ρN and ρC are smaller than
those for p1, possibly because I2 in p3 does not need to be as
centrally buried as F2 in p1 and F19 in p3 needs to be more
buried than L19 in p1. The detailed characterization of p1 and
p3 as done here in terms of not only secondary structure but
also azimuthal rotation angles is important because it reveals
that the glycine conserved at position 13 allows the two
peptides to internally kink to the same extent (as measured by
Δρ), while their diﬀerent amino acid contents lead to
diﬀerences in their absolute bilayer orientations (as measured
by ρN and ρC). On one hand, the presence of a kink improves
the amphipathicity of the peptides; on the other hand, it
introduces an imperfection to their secondary structure.
Inﬂuence of Lipid Bilayer Composition and Peptide
Amino Acid Content on Bilayer Positioning. To perform
their membrane activity, AMPs need to ﬁnd the right balance
between hydrophobic and electrostatic interactions with the
bilayer. These interactions deﬁne the bilayer position of each
peptide and ultimately the degree of bilayer remodeling and
disruption possible by the peptide. Here, the bilayer location of
p1 and p3 is found to vary in two ways. First, the depth of
insertion is inﬂuenced by the chemical nature of the amino
acids on the hydrophobic and hydrophilic sides of the peptides.
The highly conserved N-end of the peptide, which is more
hydrophobic than the C-end, contains multiple membrane-
anchoring phenylalanines as needed to satisfy strong hydro-
phobic interactions with the bilayer core. The more variable C-
end contains two out of the three of the cationic residues and
the only two nonhistidine polar residues. Moreover, it contains
only three of the peptides’ 10 hydrophobic residues and
therefore is likely responsible for membrane recognition and
disruption involving the lipid headgroups. Separate use of the
N- and C-ends for membrane anchoring and recognition has
been observed in other AMPs.
33,79,80 With the long arginine
and lysine residues in the middle of the hydrophilic face and
surrounded by ridges of shorter histidine residues, p1 and p3
may not be able to insert as deeply as if arginines and lysines
rather than histidines were at the interface between hydro-
phobic and hydrophilic sectors. With regard to p1 in PE/PG,
aromatic H17 compared to G17 in p3 and K14 compared to
R14 in p3 may explain its shallower depth of insertion
compared to p3. Second, bilayer composition aﬀects the depth
of insertion of piscidin, while its eﬀects on Δρ and the
hydrophobic moment are insigniﬁcant (Tables 2 and S3).
Similar helical rotations for optimized hydrophobic interactions
in PC/PG and PE/PG are understandable since these bilayers
have similar hydrophobic cores that attract to them the
nonpolar side of amphipathic peptides. It is intriguing that p1
and p3 are similarly active on S. aureus that lack PE but less
active on E. coli that is abundant in PE. Arguably, this could be
related to lesser insertion of the peptides in the PE-containing
bacterial membranes.
Insights into the Mechanism of Antimicrobial Peptide
Action. The mechanisms of action of AMPs, which are actively
debated, include the barrel-stave or toroidal pores, the “grab
and dip” carpet mechanism, and the disintegration of the
bilayer via micellization; however these descriptions lack
molecular details and rely on overly simpliﬁed peptide
structures.
1,3,12−16,81 Distinguishing between these mechanisms
is not straightforward. For instance, the carpet model is
described as an extension of the toroidal pore mechanism.
Recently, Wimley,
82 in the context of AMPs forming transient
pores and preferring an equilibrium orientation parallel to the
membrane, proposed interfacial activity as a semimolecular
model that builds on the carpet and toroidal pore mechanisms
and involves structures that are imperfectly amphipathic.
Interfacial activity relies on the interfacial partitioning of an
imperfectly amphipathic peptide to disrupt the vertical
segregation between the lipid polar and nonpolar moieties
and form transient pores comprised of peptides and lipids as
well as solvent and solute molecules. In this view,
permeabilization assays detect leakage from lipid vesicles
occurring when solutes follow peptide molecules that are
undergoing bilayer translocation until equilibrium concen-
trations are reached on each side of the membrane. In spite of
the debate surrounding mechanistic studies of AMPs, there is
consensus that depending on the bilayer composition of the
targets, a given AMP could combine diﬀerent mechanisms to
achieve cell death more eﬀectively. It is also understood that a
given peptide may have to rely on diﬀerent monomeric and
possibly multimeric structures to support diﬀerent steps of its
mechanisms. This mechanistic adaptability of AMPs is
consistent with the concept that the multiple structures and
functions of AMPs are optimized in the speciﬁc pathogenic
context faced by the host organism.
83
It has been postulated that piscidin kills bacteria via a carpet
mechanism leading to the formation of toroidal pores that
incorporate lipids to line the hydrophilic side of the pore.
19,28
More recently, p1 in 3:1 PC/PG bicellar preparations was
shown to disrupt 6% of the phospholipids, which acquired
mobility characteristic of micelles or small unilamellar vesicles,
as expected in the carpet model.
30 The results obtained here on
both p1 and p3 in native-like membranes provide a unique
opportunity to corroborate and add molecular details to these
modes of action, at least in terms of monomeric form of the
peptides at equilibrium. First, p1 and p3 are cationic and
amphipathic, which allows them to adopt an in-plane
orientation and accumulate on sticky anionic bilayer surfaces
as needed to reach the threshold concentration beyond which
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orientation of AMPs as ideal to induce the greatest damage to
bacterial cells because they can form “submarine-like” entities
that can “unzip” bilayers.
14 Second, p1 and p3 insert and rotate
in the bilayer in a fashion that depends on the composition of
the bilayer and amino acid content of the peptide. The strategic
positions of aromatic residues allow the N-end of the peptides
to insert more deeply in the bilayer than the C-end.
Interestingly, members of the piscidin family invariably contain
at least one phenylalanine at their amino end. In PE/PG, the
stronger interactions with the lipid headgroups occur at a cost
of reduced hydrophobic contacts with the hydrophobic core.
Notably, the lesser insertion in 1:1 PE/PG than 3:1 PC/PG
correlates with higher MICs in PE-containing bacteria. Thus,
t h en a t u r eo fp i s c i d i n −lipid interactions involving the
monomeric peptide and existing at equilibrium may prognos-
ticate the degree of disruption under nonequilibrium
conditions. Third, the kink at the end of the G(X)4G motif
conserved in piscidin
23,84−88 is preconditioned by the peptide’s
amino acid sequences and reﬂects that the N- and C-ends have
diﬀerent orientational needs to interact optimally with and
wedge themselves in the vertically segregated bilayer. While
kinking in piscidin reduces the amphipathic imperfections of
the helix, the imperfect amphipathicity reﬂected in the diﬀerent
orientations and locations of the N- and C-ends remains a
source of bilayer distortion and thinning. Interestingly, a
number of other AMPs studied in micelles also have kinks
located at glycines from G(X)nG motifs.
89−94 Most strikingly,
magainin 2 has a G(X)4G motif between G13 and G18 and a
central kink around G13,
94 which occupies a helical wheel
position similar to that of G13 in p1 and p3. Fourth, the
equilibrium state of monomeric piscidin as described above is
ﬂexible at G13, which could play an important role in allowing
the peptide to bend further, aggregate, and ﬂip in the
membrane to form transient pores. Fifth, structural and
topological diﬀerences between p1 and p3 are helpful in
identifying molecular determinants that may explain their
diﬀerent potencies. The combination of diﬀerent amino acids at
positions 14 and 17 of p1 as well as its larger volume (Figure
S4) and lesser insertion compared to p3 may be related to its
stronger biological activity in comparison to p3. The less
inserted peptide in a given lipid system may be more disruptive
because transient pores form more easily from peptides less
embedded in the membrane. In addition, p1 is amphipathically
less perfect than p3 in two ways. First, the particularly high
concentration of aromatic residues at its N-end gives it an
advantage in terms of further exacerbating the imbalance of
amphipathicity between the N- and C-ends. Second, H17 in p1
increases its polar sector and clashes with the hydrophobic
valine at position 10 (Figure 2 and green arrow in Figure S4).
These “imperfections” m a yl e a dt oe n h a n c e da b i l i t yt o
desegregate polar and nonpolar regions of the lipids and
explain why p1 is a more eﬃcacious AMP than p3. Further
discussion of the bilayer response to the presence of p1 versus
p3 and accompanying permeabilization assays in 3:1 PC/PG
and 1:1 PE/PG will take place in a subsequent paper.
■ CONCLUSION
In this research, the high-resolution structures of p1 and p3
have been solved by OS ssNMR under biologically relevant
conditions and with a level of detail that had not been
previously achieved for purely amphipathic helices. MD
simulations of the same peptides under the same conditions
provide an independent determination of conformation and
orientation. The approach presented here, which cross validates
the NMR and MD results, provides a rigorous benchmark for
the structural determination of interfacially bound α-helices and
is very well suited for the study of other amphipathic peptides
that fulﬁll important biological functions at the lipid bilayer.
These atomic-level studies were necessary to reveal critical
physicochemical features of the peptides that aﬀect their
amphipathicity and membrane-destabilizing potential, including
a kink at the end of their G(X)4G motif, and diﬀerent bilayer
orientations and positions of their N- and C-ends. In
biophysical terms, these studies provide an opportunity to
revisit the model structures used to describe the mechanisms of
action of AMPs. Speciﬁcally, results on p1 and p3 show that the
peptides are preconditioned to ﬂex at a central glycine so that
their hydrophobic moment and amphipathicity are optimized in
the bilayer and only the depth of insertion varies as function of
lipid type. Imperfect amphipathicity results from diﬀerences in
the physicochemical properties and bilayer positioning of the
N- and C-segments. Flexing and tilting in the bilayer are
advantageous to these peptides that need to adopt multiple
structures and/or orientations as part of their mechanisms of
action and adapt to changing environmental conditions. The
sequences of p1 and p3 diﬀer in several places, but the detailed
structural studies presented here indicate that the higher
potency of p1 may be achieved through strategic placement of
two key residues: aromatic F2 in the N-terminus of the peptide
enhances its anchoring capability and helical stability, while the
polar H17 in the nonpolar sector creates the type of
imperfection that enhances membrane distortion and thinning.
Overall, this research reveals that p1 and p3 adopt disrupted α-
helical structures that correct for the diﬀerent amphipathicities
of their N- and C-ends. Bound to diﬀerent bacterial cell mimics,
piscidin is tilted, kinked, and immersed in the bilayer, which
enables its disruptive eﬀects of diverse bilayers even in the
monomeric state. For the ﬁrst time, the atomic-level diﬀerences
between p1 and p3 have become available to test new
hypotheses about the modes of action of AMPs and facilitate
the design of new drugs with enhanced antimicrobial activity
and speciﬁcity for microbial membranes.
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